SEC Form 4 · accession 0001144204-17-043873
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah Romano
Officer — Interim CFO
Period of report
Aug 15, 2017
Accepted (ET)
Aug 17, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2017 | P | 10,000 | $1.00 | A | 32,500 | D |
Table II — derivative securities
No Table II lines on this filing.